GleamWall
中文EN

PRE Prenetics Global Ltd IFRS Annual reports only

Pharmaceutical Preparations · Nasdaq · SEC CIK 1876431 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY40.8%
TTM net income YoY26.2%
TTM EPS YoY33.5%
Revenue 3-yr CAGR34.7%
Net income 3-yr CAGR—

Margins

Gross margin50.3%
Operating margin-157.2%
Net margin-151.2%
FCF margin-97.6%
EBITDA margin—

Returns

ROE-24.6%
ROA-19.8%
ROIC (approx.)-27.3%
Asset turnover0.13x

Leverage & solvency

Liabilities / assets19.8%
Debt / equity0.00x
Current ratio2.36x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.62x
Accruals ratio-7.5%
Payout ratio—
Capex / revenue3.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20242024-12-31FY20232023-12-31
Income statement
Revenue$30.62M$21.74M
Cost of revenue$15.22M$12.91M
Gross profit$15.40M$8.83M
R&D expense$10.92M$11.66M
Operating income-$48.14M-$51.91M
Pretax income-$57.70M-$56.67M
Income tax-$7.87M-$269,000
Net income-$46.30M-$62.72M
EPS (basic)-3.71-5.58
EPS (diluted)-3.71-5.58
Weighted avg. shares (diluted)12.49M11.25M
Balance sheet
Cash & equivalents$52.25M$45.71M
Short-term investments$0$16.00M
Receivables$16.77M$17.66M
Inventory$6.57M$3.13M
Current assets$86.15M$93.66M
PP&E, netmay include right-of-use assets (IFRS)$7.81M$5.78M
Goodwill$37.36M$29.17M
Intangibles$11.57M$13.43M
Total assets$213.57M$254.17M
Current liabilities$36.55M$39.48M
Total liabilities$42.23M$44.01M
Shareholders' equity$170.39M$206.36M
Shares outstanding12.98M12.21M
Cash flow statement
Operating cash flow-$28.87M-$13.77M
Capital expenditure$1.01M$345,000
Free cash flow-$29.88M-$14.11M
Investing cash flow$38.54M-$82.95M
Financing cash flow-$3.34M-$4.70M
Stock-based compensation$7.85M$10.59M

Free plan shows the latest 2 periods; Pro shows all 5 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.